Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Initial brain metastasis velocity: does the rate at which cancers first seed the brain affect outcomes?

Journal of neuro-oncology·2018
Same author

Hsa_Circ_0001275: A Potential Novel Diagnostic Biomarker for Postmenopausal Osteoporosis.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology·2018
Same author

G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas.

Cell death & disease·2018
Same author

Gender specificity improves the early-stage detection of clear cell renal cell carcinoma based on methylomic biomarkers.

Biomarkers in medicine·2018
Same author

Correction to: A Graphene Oxide-Based Fluorescent Aptasensor for the Turn-on Detection of CCRF-CEM.

Nanoscale research letters·2018
Same author

Soybean Lecithin-Mediated Nanoporous PLGA Microspheres with Highly Entrapped and Controlled Released BMP-2 as a Stem Cell Platform.

Small (Weinheim an der Bergstrasse, Germany)·2018

Related Experiment Video

Updated: Apr 26, 2026

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs
08:13

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs

Published on: December 27, 2016

21.9K

Beryllium BioBank: 2. Lymphocyte proliferation testing.

Philip Harber1, Jing Su, Gabriela Alongi

  • 1From the Community, Environment, and Policy Division, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson.

Journal of Occupational and Environmental Medicine
|August 8, 2014
PubMed
Summary
This summary is machine-generated.

Improving the beryllium lymphocyte proliferation test (LPT) involves re-evaluating interpretation criteria. The stimulation index (SI) magnitude alone doesn't differentiate disease groups, but its absolute value may predict progression.

More Related Videos

Isolation and Activation of Murine Lymphocytes
08:08

Isolation and Activation of Murine Lymphocytes

Published on: October 30, 2016

21.1K
Quantification of Proliferating Human Antigen-specific CD4+ T Cells using Carboxyfluorescein Succinimidyl Ester
07:00

Quantification of Proliferating Human Antigen-specific CD4+ T Cells using Carboxyfluorescein Succinimidyl Ester

Published on: June 4, 2019

8.0K

Related Experiment Videos

Last Updated: Apr 26, 2026

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs
08:13

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs

Published on: December 27, 2016

21.9K
Isolation and Activation of Murine Lymphocytes
08:08

Isolation and Activation of Murine Lymphocytes

Published on: October 30, 2016

21.1K
Quantification of Proliferating Human Antigen-specific CD4+ T Cells using Carboxyfluorescein Succinimidyl Ester
07:00

Quantification of Proliferating Human Antigen-specific CD4+ T Cells using Carboxyfluorescein Succinimidyl Ester

Published on: June 4, 2019

8.0K

Area of Science:

  • Environmental and Occupational Health
  • Immunology
  • Toxicology

Background:

  • The beryllium lymphocyte proliferation test (LPT) is crucial for diagnosing beryllium-related lung diseases.
  • Current interpretation criteria for LPT results may not be optimal for predicting disease progression.

Purpose of the Study:

  • To enhance the predictive utility of beryllium lymphocyte proliferation test (LPT) results.
  • To investigate the relationship between LPT stimulation index (SI) and disease progression in beryllium exposure.

Main Methods:

  • Analysis of Beryllium BioBank data from 532 subjects across three groups: beryllium-exposed, sensitized, and chronic beryllium disease.
  • Utilized LPT stimulation index (SI) values at the earliest available data point and study entry as predictor variables.

Main Results:

  • Cross-sectional analysis showed LPT SI magnitude did not differentiate between the exposure, sensitization, or disease groups.
  • The absolute value of the LPT SI was associated with the likelihood of progression from sensitization to chronic beryllium disease.
  • Traditional cut-point criteria for LPT SI interpretation were not predictive of disease progression.

Conclusions:

  • Revising the interpretation criteria for beryllium LPT data is recommended.
  • Predicting progression to chronic beryllium disease could be improved by adjusting the interpretation cut-point or by analyzing the SI as a continuous variable.